Polypeptide for inhibiting degradation of nitric oxide synthase and high blood pressure and application thereof
A nitric oxide and enzymatic degradation technology, applied in the direction of peptides, drug combinations, peptide/protein components, etc., can solve the problem of reduced activity, achieve short peptide sequences, inhibit the degradation of eNOS, and broaden the selection field.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0025] In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with specific embodiments and accompanying drawings.
[0026] source of biological material
[0027] 1) TAT-PKPREPFD, TAT-PKPREPFD-Rhodamine B, and TAT-PKPREPFD-Flag were all synthesized by Beijing Zhongke Yaguang Biotechnology Co., Ltd.; 2) Fresh and healthy newborn umbilical cords were obtained from the Obstetrics and Gynecology Department of the First Affiliated Hospital of Sun Yat-sen University; 3) African green monkey kidney fibroblast cell line Cos7 was imported from ATCC in the United States and kept in our laboratory; 4) eNOS-GFP plasmid was provided by Professor Kong Deling of Nankai University in Tianjin; 5) C57BL / 6 mice were purchased from the Experimental Animal Center of Sun Yat-sen University.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com